294 related articles for article (PubMed ID: 10418827)
1. Tumor cells are the source of osteopontin and bone sialoprotein expression in human breast cancer.
Sharp JA; Sung V; Slavin J; Thompson EW; Henderson MA
Lab Invest; 1999 Jul; 79(7):869-77. PubMed ID: 10418827
[TBL] [Abstract][Full Text] [Related]
2. The LCC15-MB human breast cancer cell line expresses osteopontin and exhibits an invasive and metastatic phenotype.
Sung V; Gilles C; Murray A; Clarke R; Aaron AD; Azumi N; Thompson EW
Exp Cell Res; 1998 Jun; 241(2):273-84. PubMed ID: 9637769
[TBL] [Abstract][Full Text] [Related]
3. Detection of bone sialoprotein in human breast cancer tissue and cell lines at both protein and messenger ribonucleic acid levels.
Bellahcène A; Antoine N; Clausse N; Tagliabue E; Fisher LW; Kerr JM; Jarès P; Castronovo V
Lab Invest; 1996 Aug; 75(2):203-10. PubMed ID: 8765320
[TBL] [Abstract][Full Text] [Related]
4. Expression of bone matrix proteins in human breast cancer: potential roles in microcalcification formation and in the genesis of bone metastases.
Bellahcène A; Castronovo V
Bull Cancer; 1997 Jan; 84(1):17-24. PubMed ID: 9180854
[TBL] [Abstract][Full Text] [Related]
5. Association of increased basement membrane invasiveness with absence of estrogen receptor and expression of vimentin in human breast cancer cell lines.
Thompson EW; Paik S; Brünner N; Sommers CL; Zugmaier G; Clarke R; Shima TB; Torri J; Donahue S; Lippman ME
J Cell Physiol; 1992 Mar; 150(3):534-44. PubMed ID: 1537883
[TBL] [Abstract][Full Text] [Related]
6. In vivo implantation of human osteosarcoma cells in nude mice induces bones with human-derived osteoblasts and mouse-derived osteocytes.
Hara A; Ikeda T; Nomura S; Yagita H; Okumura K; Yamauchi Y
Lab Invest; 1996 Nov; 75(5):707-17. PubMed ID: 8941216
[TBL] [Abstract][Full Text] [Related]
7. Distribution and synthesis of bone sialoprotein in metaphyseal bone of young rats show a distinctly different pattern from that of osteopontin.
Hultenby K; Reinholt FP; Norgård M; Oldberg A; Wendel M; Heinegård D
Eur J Cell Biol; 1994 Apr; 63(2):230-9. PubMed ID: 8082647
[TBL] [Abstract][Full Text] [Related]
8. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells.
Tuck AB; Arsenault DM; O'Malley FP; Hota C; Ling MC; Wilson SM; Chambers AF
Oncogene; 1999 Jul; 18(29):4237-46. PubMed ID: 10435636
[TBL] [Abstract][Full Text] [Related]
9. Downregulation of osteopontin and bone sialoprotein II is related to reduced colony formation and metastasis formation of MDA-MB-231 human breast cancer cells.
Adwan H; Bäuerle TJ; Berger MR
Cancer Gene Ther; 2004 Feb; 11(2):109-20. PubMed ID: 14647232
[TBL] [Abstract][Full Text] [Related]
10. Cyclooxygenase-2 expression in human breast cancers and adjacent ductal carcinoma in situ.
Half E; Tang XM; Gwyn K; Sahin A; Wathen K; Sinicrope FA
Cancer Res; 2002 Mar; 62(6):1676-81. PubMed ID: 11912139
[TBL] [Abstract][Full Text] [Related]
11. Beta(3) integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontin.
Furger KA; Allan AL; Wilson SM; Hota C; Vantyghem SA; Postenka CO; Al-Katib W; Chambers AF; Tuck AB
Mol Cancer Res; 2003 Sep; 1(11):810-9. PubMed ID: 14517343
[TBL] [Abstract][Full Text] [Related]
12. Development expression of bone sialoprotein mRNA in rat mineralized connective tissues.
Chen J; Shapiro HS; Sodek J
J Bone Miner Res; 1992 Aug; 7(8):987-97. PubMed ID: 1442213
[TBL] [Abstract][Full Text] [Related]
13. Expression of bone sialoprotein and osteopontin in breast cancer bone metastases.
Ibrahim T; Leong I; Sanchez-Sweatman O; Khokha R; Sodek J; Tenenbaum HC; Ganss B; Cheifetz S
Clin Exp Metastasis; 2000; 18(3):253-60. PubMed ID: 11315099
[TBL] [Abstract][Full Text] [Related]
14. Altered expression of bone sialoproteins in vitamin D-deficient rBSP2.7Luc transgenic mice.
Chen JJ; Jin H; Ranly DM; Sodek J; Boyan BD
J Bone Miner Res; 1999 Feb; 14(2):221-9. PubMed ID: 9933476
[TBL] [Abstract][Full Text] [Related]
15. Over-expression of bone sialoprotein enhances bone metastasis of human breast cancer cells in a mouse model.
Zhang JH; Tang J; Wang J; Ma W; Zheng W; Yoneda T; Chen J
Int J Oncol; 2003 Oct; 23(4):1043-8. PubMed ID: 12963984
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity of osteopontin expression among nephrons in mouse kidneys and enhanced expression in sclerotic glomeruli.
Lopez CA; Hoyer JR; Wilson PD; Waterhouse P; Denhardt DT
Lab Invest; 1993 Sep; 69(3):355-63. PubMed ID: 8377476
[TBL] [Abstract][Full Text] [Related]
17. Attachment characteristics and involvement of integrins in adhesion of breast cancer cell lines to extracellular bone matrix components.
van der Pluijm ; Vloedgraven H; Papapoulos S; Löwick C; Grzesik W; Kerr J; Robey PG
Lab Invest; 1997 Dec; 77(6):665-75. PubMed ID: 9426405
[TBL] [Abstract][Full Text] [Related]
18. Bone sialoprotein stimulates focal adhesion-related signaling pathways: role in migration and survival of breast and prostate cancer cells.
Gordon JA; Sodek J; Hunter GK; Goldberg HA
J Cell Biochem; 2009 Aug; 107(6):1118-28. PubMed ID: 19492334
[TBL] [Abstract][Full Text] [Related]
19. Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway.
Bendre MS; Margulies AG; Walser B; Akel NS; Bhattacharrya S; Skinner RA; Swain F; Ramani V; Mohammad KS; Wessner LL; Martinez A; Guise TA; Chirgwin JM; Gaddy D; Suva LJ
Cancer Res; 2005 Dec; 65(23):11001-9. PubMed ID: 16322249
[TBL] [Abstract][Full Text] [Related]
20. Bone sialoprotein mRNA expression and ultrastructural localization in fetal porcine calvarial bone: comparisons with osteopontin.
Chen J; McKee MD; Nanci A; Sodek J
Histochem J; 1994 Jan; 26(1):67-78. PubMed ID: 8169152
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
